Showing results (201-210 of 224) with videos related to

Sort By:
Pageof 23
The Lancet. Oncology|October 24, 2023
Neoadjuvant cemiplimab and surgery for stage II-IV cutaneous squamous-cell carcinoma: follow-up and survival outcomes of a single-arm, multicentre, phase 2 studyNeil D Gross, David M Miller, Nikhil I Khushalani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2023
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical TrialMelissa L Abel, Nobuyuki Takahashi, Cody Peer, et al.
The New England Journal of Medicine|September 12, 2022
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell CarcinomaNeil D Gross, David M Miller, Nikhil I Khushalani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2021
Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and NeckRenata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, et al.
Nature Cancer|November 5, 2021
Autophagy Inhibition by Targeting PIKfyve Potentiates Response to Immune Checkpoint Blockade in Prostate CancerYuanyuan Qiao, Jae Eun Choi, Jean C Tien, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2025
Lamin A/C loss promotes R-loop-mediated genomic instability and poor survival in small-cell lung cancerChristopher W Schultz, Sourav Saha, Anjali Dhall, et al.
Cancer Discovery|April 18, 2025
Depletion of effector regulatory T cells associates with major response to induction dual immune checkpoint blockadeXianli Jiang, Nils-Petter Rudqvist, Bo Jiang, et al.
Cancer Discovery|January 30, 2023
Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse OutcomesLőrinc Sándor Pongor, Christopher W Schultz, Lorenzo Rinaldi, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
Metastatic organotropism in small cell lung cancerManan Krishnamurthy, Anjali Dhall, Sarthak Sahoo, et al.
JAMA Oncology|October 12, 2023
Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer: A Randomized Clinical TrialNobuyuki Takahashi, Zhonglin Hao, Liza C Villaruz, et al.
Pageof 23